| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-10-09 | NCT07868861 A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV… | Phase 1 | Recruiting |
| Phase 1 | 1 | |
| Phase 1/2 | 1 | |
| Phase 2/3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2/3 | ||||
| NCT07045701 | FMXIN002 in Patients at Risk of Anaphylaxis | Anaphylaxis Food | Enrolling by Invitation | 2025-07-01 |
| Phase 1/2 | ||||
| NCT07228325 | Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis | Anaphylaxis | Enrolling by Invitation | 2025-11-14 |
| Phase 1 | ||||
| NCT07868861 | A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV… | Chemotherapy-Induced Nausea and Vomiting (CINV) | Recruiting | 2026-10-09 |